Report an error

Spotted something inaccurate in “Dual-Target Gene Therapy (BBM-P002) Safe and Well-Tolerated in Phase 1 Parkinson's Trial”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.